跳至主要内容
临床试验/NCT01638988
NCT01638988撤回3 期

Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome (PCOS) and a Resistance to Insulin. Randomised Controlled Study

Clinique Ovo1 个研究点 分布在 1 个国家开始时间: 2013年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
撤回
发起方
试验地点
1
主要终点
Biochemical pregnancy

研究概览

简要总结

The results of studies conducted until now does not determine what the best way to treat infertility in the first line with patients with Polycystic ovary syndrome (PCOS). This study objective is to determine the best treatment for such patients. The long-term consequence health of women with PCOS are multiple. The woman with PCOS has a risk of developing metabolic diseases, heart diseases, diabetes Type II or anovulatory infertility. The insulin resistance plays an important role in all this medical condition. Clomiphene Citrate (CC) remains the first line treatment to induce ovulation in women with PCOS and anovulatory infertility.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women aged from 18 to 35
  • Infertility for a period of a year or more or 6 month of irregular menstrual cycle
  • PCOS under the Rotterdam criteria
  • Insulin resistance HOMA-IR > 2.5
  • Normal semen analysis values
  • Normal values of the following blood analysis: FSH, LH, Estradiol, AMH, TSH, Prolactine, Fasting glucose level, hemoglobin A1C, AST, ALT, alkaline phosphatase, SHBG, 17OH progesterone, DHEAS, Androstenedione, total testosterone, LDL, HDL, total cholesterol, Triglycerides, oral glucose tolerance test

排除标准

  • Tubular factor
  • Normal ovarian reserve
  • Prior use of CC or Metformin, hypoglycemic agents, glucocorticoids, anti-androgen, weight-loss agent or oral contraceptives in the past 6 months
  • Neoplasia
  • BMI > 35
  • Renal, hepatic or cardiac failure
  • Lactic, acidosis antecedent

研究组 & 干预措施

Metformin

Experimental

干预措施: Metformin (Drug)

Clomiphene Citrate

Active Comparator

干预措施: Clomiphene citrate (Drug)

结局指标

主要结局

Biochemical pregnancy

时间窗: 1 month

Rate of biochemical pregnancy

次要结局

  • Ovulation rate(1 month)
  • BMI and waist size changing(6 months)
  • Live birth rate(6 months)
  • AMH correlation/variation in function of Metformin(6 months)
  • Spontaneous abortion rate(6 months)
  • Insulin resistance changing(6 months)

研究者

发起方
Clinique Ovo
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验